RxDoctor Payments Data

Morgan Slawson

Gerontology · Munster, INNPI 1871194860

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 479 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,313in general payments, 2019–2025

Across 479 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Biogen$1K
  • SK Life Science, Inc.$972
  • Lundbeck LLC$566
  • UCB, Inc.$527
  • Neurelis, Inc.$398
  • plus $4K from 33 others

What the payments were for

  • Food & beverage$9,313100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,313 in reported general payments places this provider in the 95th percentile of 230 gerontology providers in Indiana.

See all gerontology providers in Indiana

Medicare billing

Part B allowed, 2024
$42,802
Medicare patients
397
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe36$28,328
Nurtec OdtRimegepant Sulfate15$17,741
NeuproRotigotine12$9,125
Rivastigmine25$6,005
Memantine Hcl103$3,078
Memantine Hcl ErMemantine Hcl31$2,891
Pregabalin48$1,696
Lacosamide13$1,472
Gabapentin106$1,425
Levetiracetam82$1,308
Donepezil Hcl93$1,033
Oxcarbazepine11$908
Carbidopa-LevodopaCarbidopa/Levodopa57$841
Divalproex Sodium33$827
Carbidopa-Levodopa ErCarbidopa/Levodopa20$619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$391$17,74115 claims
UCB, Inc.Neupro$527$9,12512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 230 gerontology providers in Indiana.

Other gerontology in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →